ITMN

ITMN: To Present At Lazard Capital Healthcare Conference @ 15:10 ET [delayed] - 11/18 - 01:54 PM ET

InterMune to Present at Lazard Capital Markets Healthcare Conference - 11/14 - 08:00 AM ET

BRIEF-InterMune reports Q3 results - 11/06 - 04:11 PM ET

InterMune Reports Third Quarter 2008 Financial Results and Business Highlights - 11/06 - 04:00 PM ET

ITMN: Q3 Earnings Call @ 16:30 ET Today [delayed] - 11/06 - 01:50 PM ET

InterMune announces receipt of Japanese Regulatory Approval for pirfenidone for IPF - 10/17 - 07:56 AM ET

InterMune Drops Sharply, Challenges Support - 10/16 - 01:24 PM ET

InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF - 10/16 - 11:54 AM ET

InterMune Sinks Below 200-Day Moving Average - 10/03 - 11:45 AM ET

InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting - 09/24 - 09:05 AM ET

ITMN: To Present At Baird Small Cap Health Care Conference @ 10:30 ET [delayed] - 09/10 - 08:54 AM ET

InterMune to Present at Baird Small Cap Healthcare Conference - 09/08 - 08:00 AM ET

ITMN: To Present At Thomas Weisel Healthcare Conference @ 10:55 ET [delayed] - 09/04 - 09:23 AM ET

InterMune Inc receives development milestone payment for HCV protease inhibitor - 09/03 - 10:43 AM ET

ITMN: To Receive $15M Development Milestone Under Collaboration w/Roche - 09/02 - 08:57 AM ET

InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche - 09/02 - 08:00 AM ET

InterMune to Present at Thomas Weisel Partners Healthcare Conference - 08/29 - 12:19 PM ET

ITMN: To Present At Canaccord Adams Global Growth Conference @ 13:00 ET [delayed] - 08/13 - 11:23 AM ET

InterMune to Present at Canaccord Adams Conference - 08/07 - 04:00 PM ET

ITMN: To Present At BMO Focus on Healthcare Conference @ 10:00 ET [delayed] - 08/06 - 08:27 AM ET

Page 1 of 6     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index